Cargando…
Fats, Friends or Foes: Investigating the Role of Short- and Medium-Chain Fatty Acids in Alzheimer’s Disease
Characterising Alzheimer’s disease (AD) as a metabolic disorder of the brain is gaining acceptance based on the pathophysiological commonalities between AD and major metabolic disorders. Therefore, metabolic interventions have been explored as a strategy for brain energetic rescue. Amongst these, me...
Autores principales: | Ameen, Aishat O., Freude, Kristine, Aldana, Blanca I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9687972/ https://www.ncbi.nlm.nih.gov/pubmed/36359298 http://dx.doi.org/10.3390/biomedicines10112778 |
Ejemplares similares
-
Short-chain fatty acids in blood pressure, friend or foe
por: Chen, Xiao-Feng, et al.
Publicado: (2021) -
Dietary fatty acids: Friends or Foes?
por: Yadav, Hariom, et al.
Publicado: (2015) -
Glial Cells in Glaucoma: Friends, Foes, and Potential Therapeutic Targets
por: García-Bermúdez, Mariana Y., et al.
Publicado: (2021) -
Non-esterified fatty acids in the ovary: friends or foes?
por: Baddela, Vijay Simha, et al.
Publicado: (2020) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)